会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • 6,7- DIHYDROIMIDAZO [1,5-A] PYRAZIN-8 (5H) - ONE DERIVATIVES AS PROTEIN KINASE MODULATORS
    • 6,7-二氢吲哚并[1,5-A]吡嗪-8(5H) - 一种衍生物作为蛋白激酶调节剂
    • WO2011092120A1
    • 2011-08-04
    • PCT/EP2011/050846
    • 2011-01-21
    • NERVIANO MEDICAL SCIENCES S.r.l.MIRIZZI, DaniloORRENIUS, Sten ChristianTRIFIRO', Paolo
    • MIRIZZI, DaniloORRENIUS, Sten ChristianTRIFIRO', Paolo
    • C07D487/04A61K31/4985A61P35/00
    • C07D487/04
    • There are provided 3,5-disubstituted derivatives of 6,7-dihydroimidazo[1,5-a]pyrazin-8(5H)-one compounds of formula (I) or a pharmaceutically acceptable salt thereof as defined in the present specification, which modulate the activity of protein kinases. The compounds are therefore useful in treating diseases caused by dysregulated protein kinase activity. In particular, such diseases to be treated with a compound of formula (I) of the present invention is one caused by and/or associated with disregulated protein kinase activity selected from the group consisting of cancer, viral infection, prevention of AIDS development in HIV-infected individuals, cell proliferative disorders, autoimmune and neurodegenerative disorders. The present invention also relates to processes for preparing the compounds of formula (I), combinatorial libraries thereof, pharmaceutical compositions comprising them, and methods of treating diseases utilizing pharmaceutical compositions comprising a compound of formula (I).
    • 提供了本说明书中定义的式(I)的6,7-二氢咪唑并[1,5-a]吡嗪-8(5H) - 酮化合物或其药学上可接受的盐的3,5-二取代衍生物,其中 调节蛋白激酶的活性。 因此,这些化合物可用于治疗由失调的蛋白激酶活性引起的疾病。 特别地,用本发明的式(I)化合物治疗的这些疾病是由选自下组的失调的蛋白激酶活性引起的和/或与其相关的,所述蛋白激酶活性选自癌症,病毒感染,HIV预防艾滋病发展 感染的个体,细胞增殖性疾病,自身免疫和神经变性疾病。 本发明还涉及制备式(I)化合物的方法,其组合文库,包含它们的药物组合物,以及使用包含式(I)化合物的药物组合物治疗疾病的方法。